"The board-certified medical oncologists, radiation oncologists and surgeons who staff our west county facility also practice at Siteman’s main campus in St. Louis and collaborate regularly with other Siteman and Washington University physicians. In addition many Siteman surgeons and specialists practice in other offices on the campus of Barnes-Jewish West County Hospital, making it possible to receive comprehensive care in one location. The staff also includes registered nurses with specialized training in caring for cancer patients. A research coordinator is available to talk with patients about possible participation in clinical trials, which provide access to new medications and treatments not available at most cancer centers."

During the past decade, Siteman Cancer Center at West County Hospital conducted 180 clinical trials. In the 10-year time frame, 180 clinical trials started and 57 clinical trials were completed, i.e. on average, 31.7% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 40 clinical trials were completed. i.e. 75.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siteman Cancer Center at West County Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 115 trials, followed by "Pfizer" with 28 trials sponsored, "SWOG Cancer Research Network" with 23 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored and "NRG Oncology" with 22 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siteman Cancer Center at West County Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Siteman Cancer Center at West County Hospital" are "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Siteman Cancer Center at West County Hospital" in a lesser frequency.

Most popular intervention types in "Siteman Cancer Center at West County Hospital" are "Drug" (189 trials), "Other" (106 trials), "Biological" (90 trials), "Procedure" (74 trials) and "Radiation" (61 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (47 trials), "Laboratory Biomarker Analysis" (46 trials), "Computed Tomography" (39 trials), "Biospecimen Collection" (37 trials) and "Questionnaire Administration" (35 trials). Other intervention names were less common.

The vast majority of trials in "Siteman Cancer Center at West County Hospital" are 210 trials for "All" genders, 15 trials for "Male" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Siteman Cancer Center at West County Hospital". undefined are not yet recruiting, 89 are recruiting, 95 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Siteman Cancer Center at West County Hospital, 13 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Siteman Cancer Center at West County Hospital, 33 "Phase 1" clinical trials were conducted, 123 "Phase 2" clinical trials and 100 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".